<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>205(3)</volume><submitter>Epperla N</submitter><funding>Medical College of Wisconsin</funding><funding>Health Resources and Services Administration</funding><funding>Office of Naval Research</funding><funding>NMDP</funding><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Pediatric Blood and Marrow Transplant Consortium</funding><funding>National Heart, Lung and Blood Institute</funding><funding>HRSA HHS</funding><funding>Gateway for Cancer Research</funding><funding>National Marrow Donor Program</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>Pediatric Transplantation and Cellular Therapy Consortium</funding><journal>British journal of haematology</journal><pagination>1202-1207</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11499028</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.</pubmed_title><pmcid>PMC11499028</pmcid><funding_grant_id>75R60222C00011</funding_grant_id><funding_grant_id>N00014‐24‐1‐2507</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>N00014-24-1-2507</funding_grant_id><funding_grant_id>U24 CA076518</funding_grant_id><funding_grant_id>U24CA076518</funding_grant_id><funding_grant_id>N00014‐23‐1‐2057</funding_grant_id><funding_grant_id>N00014-23-1-2057</funding_grant_id><pubmed_authors>Chen AI</pubmed_authors><pubmed_authors>Scordo M</pubmed_authors><pubmed_authors>Ahmed S</pubmed_authors><pubmed_authors>Hashmi H</pubmed_authors><pubmed_authors>Kanakry JA</pubmed_authors><pubmed_authors>Sauter C</pubmed_authors><pubmed_authors>Herrera AF</pubmed_authors><pubmed_authors>Lekakis L</pubmed_authors><pubmed_authors>Kharfan-Dabaja MA</pubmed_authors><pubmed_authors>Ahn KW</pubmed_authors><pubmed_authors>Hamadani M</pubmed_authors><pubmed_authors>Epperla N</pubmed_authors><pubmed_authors>Allbee-Johnson M</pubmed_authors><pubmed_authors>Shadman M</pubmed_authors><pubmed_authors>Riedell PA</pubmed_authors><pubmed_authors>Jain T</pubmed_authors><pubmed_authors>Wirk B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-05-28T20:21:52.643Z</modification><creation>2026-04-08T03:02:39.313Z</creation></dates><accession>S-EPMC11499028</accession><cross_references><pubmed>38797526</pubmed><doi>10.1111/bjh.19569</doi></cross_references></HashMap>